Ra Capital Management, L.P. Kala Pharmaceuticals, Inc. Transaction History

Ra Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $3.26 Million - $14.2 Million	-10,874,613 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $24.3 Million - $55.7 Million	6,337,135 Added 139.66%	10,874,613 $95.6 Million
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $10.4 Million - $24.1 Million	2,424,242 Added 114.72%	4,537,478 $22.2 Million
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $42 Million - $56.1 Million	2,113,236	2,113,236 $48.3 Million

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.